Home LiteratureArticle Details
PMID: 16227599 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Class IA phosphoinositide 3-kinase regulates heart size and physiological cardiac hypertrophy.

Molecular and cellular biology ·Vol. 25 ·No. 21 ·2005-11-00 ·Pages 9491-502

Luo J, McMullen JR, Sobkiw CL, Zhang L, Dorfman AL, Sherwood MC, Logsdon MN, Horner JW, DePinho RA, Izumo S, Cantley LC

Abstract

Class I(A) phosphoinositide 3-kinases (PI3Ks) are activated by growth factor receptors, and they regulate, among other processes, cell growth and organ size. Studies using transgenic mice overexpressing constitutively active and dominant negative forms of the p110alpha catalytic subunit of class I(A) PI3K have implicated the role of this enzyme in regulating heart size and physiological cardiac hypertrophy. To further understand the role of class I(A) PI3K in controlling heart growth and to circumvent potential complications from the overexpression of dominant negative and constitutively active proteins, we generated mice with muscle-specific deletion of the p85alpha regulatory subunit and germ line deletion of the p85beta regulatory subunit of class I(A) PI3K. Here we show that mice with cardiac deletion of both p85 subunits exhibit attenuated Akt signaling in the heart, reduced heart size, and altered cardiac gene expression. Furthermore, exercise-induced cardiac hypertrophy is also attenuated in the p85 knockout hearts. Despite such defects in postnatal developmental growth and physiological hypertrophy, the p85 knockout hearts exhibit normal contractility and myocardial histology. Our results therefore provide strong genetic evidence that class I(A) PI3Ks are critical regulators for the developmental growth and physiological hypertrophy of the heart.

MeSH Terms
Adaptation, Physiological Animals Cardiomegaly/pathology,physiopathology Catalytic Domain/genetics,physiology Cells, Cultured Gene Expression Regulation Heart/anatomy & histology,physiology Mice Mice, Knockout Muscle Cells/pathology Myocardium/enzymology,pathology Oncogene Protein v-akt/metabolism Phosphatidylinositol 3-Kinases/genetics,physiology Physical Conditioning, Animal Signal Transduction
Chemicals
Phosphatidylinositol 3-Kinases Oncogene Protein v-akt
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Luo Ji
Division of Systems Biology, Harvard Medical School, Beth Israel Deaconess Medical Center, 77 Avenue Louis Pasteur, 10th Floor, Boston, MA 02115, USA.
McMullen Julie R
Sobkiw Cassandra L
Zhang Li
Dorfman Adam L
Sherwood Megan C
Logsdon M Nicole
Horner James W
DePinho Ronald A
Izumo Seigo
Cantley Lewis C
References (55)
55 references, click to expand
  1. Cardiac hypertrophy: the good, the bad, and the ugly.
    Annu Rev Physiol. 2003;65:45-79 PMID: 12524460
  2. The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling.
    J Biol Chem. 2005 May 27;280(21):20814-23 PMID: 15781459
  3. A friend within the heart: natriuretic peptide receptor signaling.
    J Clin Invest. 2003 May;111(9):1275-7 PMID: 12727915
  4. Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A.
    J Clin Invest. 2003 May;111(9):1399-407 PMID: 12727932
  5. Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2.
    Mol Cell. 2003 Jun;11(6):1457-66 PMID: 12820960
  6. Role of phosphoinositide 3-kinase in cardiac function and heart failure.
    Trends Cardiovasc Med. 2003 Jul;13(5):206-12 PMID: 12837584
  7. Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb.
    Curr Biol. 2003 Aug 5;13(15):1259-68 PMID: 12906785
  8. PTEN: from pathology to biology.
    Trends Cell Biol. 2003 Sep;13(9):478-83 PMID: 12946627
  9. Deficiency of PDK1 in cardiac muscle results in heart failure and increased sensitivity to hypoxia.
    EMBO J. 2003 Sep 15;22(18):4666-76 PMID: 12970179
  10. Phosphoinositide 3-kinase(p110alpha) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy.
    Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12355-60 PMID: 14507992
  11. p50alpha/p55alpha phosphoinositide 3-kinase knockout mice exhibit enhanced insulin sensitivity.
    Mol Cell Biol. 2004 Jan;24(1):320-9 PMID: 14673165
  12. The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase(p110alpha) pathway.
    J Biol Chem. 2004 Feb 6;279(6):4782-93 PMID: 14597618
  13. Phosphoinositide 3-kinase gamma: kinase-dependent and -independent activities in cardiovascular function and disease.
    Biochem Soc Trans. 2004 Apr;32(Pt 2):383-6 PMID: 15046613
  14. Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression.
    Oncogene. 2004 Apr 19;23(18):3151-71 PMID: 15094765
  15. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy.
    Cell. 2004 Apr 30;117(3):399-412 PMID: 15109499
  16. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors.
    Mol Cell. 2004 May 7;14(3):395-403 PMID: 15125842
  17. Deletion of ribosomal S6 kinases does not attenuate pathological, physiological, or insulin-like growth factor 1 receptor-phosphoinositide 3-kinase-induced cardiac hypertrophy.
    Mol Cell Biol. 2004 Jul;24(14):6231-40 PMID: 15226426
  18. PI3Kgamma modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effects.
    Cell. 2004 Aug 6;118(3):375-87 PMID: 15294162
  19. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity.
    Nature. 2004 Sep 9;431(7005):200-5 PMID: 15306821
  20. Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload.
    Proc Natl Acad Sci U S A. 1988 Jan;85(2):339-43 PMID: 2963328
  21. Identification of upstream and intragenic regulatory elements that confer cell-type-restricted and differentiation-specific expression on the muscle creatine kinase gene.
    Mol Cell Biol. 1988 Jul;8(7):2896-909 PMID: 3405222
  22. Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt.
    Science. 1999 Nov 26;286(5445):1738-41 PMID: 10576741
  23. Phosphorylation and regulation of Raf by Akt (protein kinase B).
    Science. 1999 Nov 26;286(5445):1741-4 PMID: 10576742
  24. Inhibitory regulation of hypertrophy by endogenous atrial natriuretic peptide in cultured cardiac myocytes.
    Hypertension. 2000 Jan;35(1 Pt 1):19-24 PMID: 10642269
  25. The conserved phosphoinositide 3-kinase pathway determines heart size in mice.
    EMBO J. 2000 Jun 1;19(11):2537-48 PMID: 10835352
  26. Hypoglycaemia, liver necrosis and perinatal death in mice lacking all isoforms of phosphoinositide 3-kinase p85 alpha.
    Nat Genet. 2000 Nov;26(3):379-82 PMID: 11062485
  27. A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy.
    Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2703-6 PMID: 11226303
  28. Increased insulin sensitivity in mice lacking p85beta subunit of phosphoinositide 3-kinase.
    Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):419-24 PMID: 11752399
  29. Seven-transmembrane-spanning receptors and heart function.
    Nature. 2002 Jan 10;415(6868):206-12 PMID: 11805844
  30. Akt/protein kinase B promotes organ growth in transgenic mice.
    Mol Cell Biol. 2002 Apr;22(8):2799-809 PMID: 11909972
  31. Early embryonic lethality in mice deficient in the p110beta catalytic subunit of PI 3-kinase.
    Mamm Genome. 2002 Mar;13(3):169-72 PMID: 11919689
  32. The phosphoinositide 3-kinase pathway.
    Science. 2002 May 31;296(5573):1655-7 PMID: 12040186
  33. Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart.
    J Biol Chem. 2002 Jun 21;277(25):22896-901 PMID: 11943770
  34. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway.
    Mol Cell. 2002 Jul;10(1):151-62 PMID: 12150915
  35. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling.
    Nat Cell Biol. 2002 Sep;4(9):648-57 PMID: 12172553
  36. Akt regulates growth by directly phosphorylating Tsc2.
    Nat Cell Biol. 2002 Sep;4(9):658-65 PMID: 12172554
  37. Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways.
    Cell. 2002 Sep 20;110(6):737-49 PMID: 12297047
  38. Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling.
    Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13571-6 PMID: 12271141
  39. Phosphoinositide 3-kinase gamma: a key modulator in inflammation and allergy.
    Biochem Soc Trans. 2003 Feb;31(Pt 1):275-80 PMID: 12546701
  40. Cardiac adaptations to chronic exercise in mice.
    Am J Physiol. 1994 Sep;267(3 Pt 2):H1167-73 PMID: 8092282
  41. Structural organization and alternative splicing of the murine phosphoinositide 3-kinase p85 alpha gene.
    Genomics. 1996 Oct 1;37(1):113-21 PMID: 8921377
  42. The G beta gamma sensitivity of a PI3K is dependent upon a tightly associated adaptor, p101.
    Cell. 1997 Apr 4;89(1):105-14 PMID: 9094719
  43. Impact of different sports and training on cardiac structure and function.
    Cardiol Clin. 1997 Aug;15(3):397-412 PMID: 9276165
  44. Regulation of the p85/p110 phosphatidylinositol 3'-kinase: stabilization and inhibition of the p110alpha catalytic subunit by the p85 regulatory subunit.
    Mol Cell Biol. 1998 Mar;18(3):1379-87 PMID: 9488453
  45. Inducible gene targeting in mice using the Cre/lox system.
    Methods. 1998 Apr;14(4):381-92 PMID: 9608509
  46. Phosphoinositide kinases.
    Annu Rev Biochem. 1998;67:481-507 PMID: 9759495
  47. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance.
    Mol Cell. 1998 Nov;2(5):559-69 PMID: 9844629
  48. Xid-like immunodeficiency in mice with disruption of the p85alpha subunit of phosphoinositide 3-kinase.
    Science. 1999 Jan 15;283(5400):390-2 PMID: 9888854
  49. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha.
    Science. 1999 Jan 15;283(5400):393-7 PMID: 9888855
  50. Increased insulin sensitivity and hypoglycaemia in mice lacking the p85 alpha subunit of phosphoinositide 3-kinase.
    Nat Genet. 1999 Feb;21(2):230-5 PMID: 9988280
  51. Proliferative defect and embryonic lethality in mice homozygous for a deletion in the p110alpha subunit of phosphoinositide 3-kinase.
    J Biol Chem. 1999 Apr 16;274(16):10963-8 PMID: 10196176
  52. Signaling pathways for cardiac hypertrophy and failure.
    N Engl J Med. 1999 Oct 21;341(17):1276-83 PMID: 10528039
  53. A mouse model of cardiac rhabdomyoma generated by loss of Tsc1 in ventricular myocytes.
    Hum Mol Genet. 2005 Feb 1;14(3):429-35 PMID: 15601645
  54. Role of phosphoinositide 3-kinase regulatory isoforms in development and actin rearrangement.
    Mol Cell Biol. 2005 Apr;25(7):2593-606 PMID: 15767666
  55. Rapamycin attenuates load-induced cardiac hypertrophy in mice.
    Circulation. 2003 Apr 1;107(12):1664-70 PMID: 12668503
Article Info
Journal
Molecular and cellular biology
Abbr.
Mol Cell Biol
ISSN
0270-7306
Published
2005-11-00
Pages
9491-502
Language
English
Region
United States
NLM ID
8109087
PMCID
PMC1265829
Subset
IM
Grants
NHLBI NIH HHS · R01 HL 65742 · United States
NCI NIH HHS · CA 089021 · United States
NHLBI NIH HHS · R01 HL065742 · United States
NIGMS NIH HHS · R37 GM041890 · United States
NIGMS NIH HHS · R01 GM041890 · United States
NCI NIH HHS · P01 CA089021 · United States
NIGMS NIH HHS · GM 41890 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com